APA (7th ed.) Citation

Liang, G., Wang, L., You, Q., Cahill, K., Chen, C., Zhang, W., . . . Han, D. (2023). Cellular Composition and 5hmC Signature Predict the Treatment Response of AML Patients to Azacitidine Combined with Chemotherapy. Advanced Science, 10(23), 1. https://doi.org/10.1002/advs.202300445

Chicago Style (17th ed.) Citation

Liang, Guanghao, et al. "Cellular Composition and 5hmC Signature Predict the Treatment Response of AML Patients to Azacitidine Combined with Chemotherapy." Advanced Science 10, no. 23 (2023): 1. https://doi.org/10.1002/advs.202300445.

MLA (9th ed.) Citation

Liang, Guanghao, et al. "Cellular Composition and 5hmC Signature Predict the Treatment Response of AML Patients to Azacitidine Combined with Chemotherapy." Advanced Science, vol. 10, no. 23, 2023, p. 1, https://doi.org/10.1002/advs.202300445.